Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Kamel Debbi"'
Autor:
Yazid Belkacemi, MD, PhD, Gabriele Coraggio, MD, Anne Brunel, PhD, Annie Jouhaud, DM, Alexandre Ingels, MD, PhD, Charlotte Joly, MD, Asma Hadhri, MD, Wissal Hassani, MD, Gokoulakrichenane Loganadane, MD, Carolina Saldana, MD, PhD, Nabila Ouidir, MD, Barbara Vega, PhD, Kamel Debbi, MD, Alexandre de La Taille, MD, PhD
Publikováno v:
Advances in Radiation Oncology, Vol 8, Iss 5, Pp 101255- (2023)
Purpose: Androgen deprivation therapy (ADT) may cause vasomotor symptoms (VMS) including hot flushes and sweats, which affect quality of life (QoL). Serelys Homme is a nonhormonal and a natural origin product that could affect VMS in men undergoing A
Externí odkaz:
https://doaj.org/article/ee833dcd60964a2b8625b0355ab06172
Autor:
Mohamed Aziz Cherif, MD, Gokoulakrichenane Loganadane, MD, Kamel Debbi, MD, Gabriele Coraggio, MD, Sahar Ghith, MD, Asma Hadhri, MD, Wissal Hassani, MD, Noémie Grellier, MD, Nhu Hanh To, MD, Yazid Belkacemi, MD, PhD
Publikováno v:
Advances in Radiation Oncology, Vol 6, Iss 4, Pp 100626- (2021)
Purpose: The management of older patients in radiation therapy (RT) departments has been challenging in the context of the Coronavirus Disease 2019 (COVID-19) outbreak. We report our experience of RT adapted schedules or strategy changes in older pat
Externí odkaz:
https://doaj.org/article/01db2ba6479c45abad2210432a3da2e8
Autor:
Nhu Hanh To, Caroline Pilon, Audrey Moatti, Anaïs Debesset, Kamel Debbi, Gabriele Coraggio, Wassim Ksouri, Virginie Massaria, José L. Cohen, Yazid Belkacemi, Allan Thiolat
Publikováno v:
Strahlentherapie und Onkologie.
Outcomes and Side Effects of Preoperative Chemoradiotherapy for Locally Advanced Upper Rectal Cancer
Autor:
SANDRA CHOMICKI, SOPHIE CHAPET, MOUSSATA DRIFA, MEHDI OUAISSI, PASCAL BOURLIER, KAMEL DEBBI, GOKOULAKRICHENANE LOGANADANE, GILLES CALAIS
Publikováno v:
Anticancer research. 42(10)
The benefit of neoadjuvant (chemo) radiotherapy for locally advanced upper rectal tumors remains controversial. Thus, we aimed to evaluate the outcome of patients with stage II or-III upper rectal cancer undergoing neoadjuvant (chemo) radiotherapy fo
Autor:
Kamel, Debbi, Gokoulakrichenane, Loganadane, Nhu Hanh, To, Remy, Kinj, Zain A, Husain, Sophie, Chapet, Nam P, Nguyen, Isabelle, Barillot, Karen, Benezery, Yazid, Belkacemi, Gilles, Calais
Publikováno v:
The British Journal of Radiology. 95
Objectives: The aim of this retrospective study was to assess outcomes of SABR for metachronous isolated lung oligometastases from HNSCC. Methods: For patients who developed isolated, 1 or 2 lungs lesions (Results: Between November 2007 and February
Autor:
Kamel Debbi, Noémie Grellier, Gokoulakrichenane Loganadane, Chahrazed Boukhobza, Mathilde Mahé, Mohamed Aziz Cherif, Hanan Rida, Joseph Gligorov, Yazid Belkacemi
Publikováno v:
Cancers. 15:2278
Purpose: Over the past twenty years, anti-HER2 targeted therapies have proven to be a revolution in the management of human epidermal growth receptor 2 (HER2)-positive breast cancers. Anti-HER2 therapies administered alone or in combination with chem
Autor:
Yazid Belkacemi, Kamel Debbi, Gabriele Coraggio, Jérome Bendavid, Maya Nourieh, Nhu Hanh To, Mohamed Aziz Cherif, Carolina Saldana, Alexandre Ingels, Alexandre De La Taille, Gokoulakrichenane Loganadane
Publikováno v:
Cancers
Volume 15
Issue 3
Pages: 945
Volume 15
Issue 3
Pages: 945
Genomic classifiers such as the Genomic Prostate Score (GPS) could help to personalize treatment for men with intermediate-risk prostate cancer (I-PCa). In this study, we aimed to evaluate the ability of the GPS to change therapeutic decision making
Autor:
Kamel Debbi, Yazid Belkacemi, Gokoulakrichenane Loganadane, Asma Hadhri, Mohamed Aziz Cherif, Nhu Hanh To, Sahar Ghith, Noémie Grellier, Wissal Hassani, Gabriele Coraggio
Publikováno v:
Advances in Radiation Oncology
Advances in Radiation Oncology, Vol 6, Iss 4, Pp 100626-(2021)
Advances in Radiation Oncology, Vol 6, Iss 4, Pp 100626-(2021)
Purpose: The management of older patients in radiation therapy (RT) departments has been challenging in the context of the Coronavirus Disease 2019 (COVID-19) outbreak. We report our experience of RT adapted schedules or strategy changes in older pat
Autor:
M.L. Herve, M.A. Cherif, L. Colson Durand, Nhu Hanh To, L. Filliard, Nicolas Foray, Noémie Grellier, S. Chomicki, Kamel Debbi, Gloria Fonteneau, A. Bak, C. Besnard, Sahar Ghith, G. Corragio, D. Azria, G. Loganadane, C. Le Bret, Y. Belkacemi, L. Djebbar, M. Rahmoun, E. Tang, D. Jerroudi
Publikováno v:
Cancer/Radiothérapie. 25:731-732
Introduction et but de l’etude La radiotherapie externe peut etre a l’origine de nombreuses toxicites selon les parametres dosimetriques, les traitements associes ou la radiosensibilite intrinseque des patients. La revue de morbimortalite est un
Autor:
Kamel Debbi, Davorin Radosavljevic, Vladimir Todorovic, Aziz Cherif, Semir Beslija, Milan Risteski, Fady Geara, Dusanka Tesanovic, Siniša Radulović, Damir Vrbanec, Liljana Stamatovic, Gabriele Coraggio, Mladen Filipovic, Ivan Marković, Salvador Villà Freixa, Hassan Errihani, Oliver Arsovski, Giorgio Mustacchi, Jean Pierre Lotz, Radan Dzodic, Igor Stojkovski, Adda Bounedjar, Yazid Belkacemi, Lazar Popovic, Marco Krengli, Marie Pierre Chauvet, R Samlali, Jean Philippe Spano, Nino Vasev, Sahar Ghith, Nina Radosevic, Ahmed Idbaih, Alphonse G. Taghian, Mahmut Ozsahin, Noémie Grellier, K. Bouzid, Abraham Kuten, Farouk Benna, Hamouda Boussen, Joseph Gligorov, Hahn To, Suzana Vasovic, Khaldoun Kerrou, Sedat Turkan, Karima Mokhtari, Pauletta G. Tsoutsou, V. Kovcin, Souha Sahraoui
Publikováno v:
European Journal of Cancer
European Journal of Cancer, Vol. 135 (2020) pp. 130-146
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
European journal of cancer, vol. 135, pp. 130-146
European Journal of Cancer, Vol. 135 (2020) pp. 130-146
r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
instname
European journal of cancer, vol. 135, pp. 130-146
Coronavirus disease 2019 (COVID-19) is an infectious disease caused by a new virus that has never been identified in humans before. COVID-19 caused at the time of writing of this article, 2.5 million cases of infections in 193 countries with 165,000